GlassScriptPhysician profile
Suzanne Crocker
NPI 1811385057
$1,147.96
in general payments reported to CMS, 2019-2025
14 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $401 · 2023: $394 · 2024: $94.34 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $327.60 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $280.02 | 2021-2025 | Xtampza |
| Novo Nordisk INC | $117.72 | 2023 | Wegovy |
| Averitas Pharma INC. | $109.99 | 2023 | Qutenza |
| Almatica Pharma LLC | $90.52 | 2021-2023 | Gralise |
| Abbvie INC. | $73.62 | 2023-2025 | |
| Protega Pharmaceutials INC | $28.53 | 2023 | Roxybond |
| Saluda Medical Americas, INC. | $26.16 | 2023 | Evoke Scs |
| Pacira Pharmaceuticals Incorporated | $22.34 | 2024 | Exparel, Zilretta, Iovera |
| W. L. Gore & Associates, INC. | $18.35 | 2021 | |
| Medtronic, INC. | $17.10 | 2021 | |
| Boston Scientific Corporation | $16.91 | 2025 | Spectra Wavewriter |
| Redhill Biopharma INC. | $13.24 | 2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $5.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Crocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.